SPTAN1 and hereditary spastic paraplegia: SPTAN1 was investigated as a candidate gene for HA or HSP using gene enrichment analysis in the rare disease component of the 100K GP, which has a total of 35,422 rare disease families, including 1142 HA/HSP probands as cases and 23,847 non-neurologic/non-metabolic unrelated individuals as controls.